The purpose of this statement is to inform practitioners about new information concerning lack of demonstrated clinical effectiveness of ribavirin in the treatment of infants with respiratory syncytial virus (RSV) disease. The intent of the new recommendation is to allow practitioners to decide whether ribavirin therapy is appropriate or not by taking into account the particular clinical situation and their own preferences. More definitive answers to the questions of ribavirin efficacy and effectiveness will require multi-institutional, prospective, randomized clinical trials. Recommendations may be modified as new information becomes available.
This article has been cited by other articles:
![]() |
J. S. Kahn Epidemiology of Human Metapneumovirus Clin. Microbiol. Rev., July 1, 2006; 19(3): 546 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Easton, J. B. Domachowske, and H. F. Rosenberg Animal Pneumoviruses: Molecular Genetics and Pathogenesis Clin. Microbiol. Rev., April 1, 2004; 17(2): 390 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. King, M. Viswanathan, W. C. Bordley, A. M. Jackman, S. F. Sutton, K. N. Lohr, and T. S. Carey Pharmacologic Treatment of Bronchiolitis in Infants and Children: A Systematic Review Arch Pediatr Adolesc Med, February 1, 2004; 158(2): 127 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. McCarthy and C. B. Hall Respiratory Syncytial Virus: Concerns and Control Pediatr. Rev., September 1, 2003; 24(9): 301 - 309. [Full Text] [PDF] |
||||
![]() |
A. Hu, M. Colella, J. S. Tam, R. Rappaport, and S.-M. Cheng Simultaneous Detection, Subgrouping, and Quantitation of Respiratory Syncytial Virus A and B by Real-Time PCR J. Clin. Microbiol., January 1, 2003; 41(1): 149 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bonville, A. J. Easton, H. F. Rosenberg, and J. B. Domachowske Altered Pathogenesis of Severe Pneumovirus Infection in Response to Combined Antiviral and Specific Immunomodulatory Agents J. Virol., December 20, 2002; 77(2): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Edell, V. Khoshoo, G. Ross, and K. Salter Early Ribavarin Treatment of Bronchiolitis* : Effect on Long-term Respiratory Morbidity Chest, September 1, 2002; 122(3): 935 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Meissner Uncertainty in the Management of Viral Lower Respiratory Tract Disease Pediatrics, October 1, 2001; 108(4): 1000 - 1003. [Full Text] [PDF] |
||||
![]() |
A. R. Falsey and E. E. Walsh Respiratory Syncytial Virus Infection in Adults Clin. Microbiol. Rev., July 1, 2000; 13(3): 371 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Khoshoo, D. Edell, and A.-M. GUERGUERIAN RIBAVARIN IN VENTILATED RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 333 - 334. [Full Text] |
||||
![]() |
A.-M. GUERGUERIAN, M. GAUTHIER, M. H. LEBEL, C. A. FARRELL, and J. LACROIX Ribavirin in Ventilated Respiratory Syncytial Virus Bronchiolitis . A Randomized, Placebo-controlled Trial Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 829 - 834. [Abstract] [Full Text] |
||||
![]() |
J. B. Domachowske and H. F. Rosenberg Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment Clin. Microbiol. Rev., April 1, 1999; 12(2): 298 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. W. MOLER and S. E. OHMIT Severity Of Illness Models For Respiratory Syncytial Virus-Associated Hospitalization Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1234 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
Committee on Infectious Diseases and Committee on Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV Pediatrics, November 1, 1998; 102(5): 1211 - 1216. [Abstract] [Full Text] |
||||
![]() |
T. Darville and T. Yamauchi Respiratory Syncytial Virus Pediatr. Rev., February 1, 1998; 19(2): 55 - 61. [Full Text] [PDF] |
||||
![]() |
H. C. Meissner and J. R. Groothuis Immunoprophylaxis and the Control of RSV Disease Pediatrics, August 1, 1997; 100(2): 260 - 260. [Full Text] [PDF] |
||||
![]() |
Committee on Infectious Diseases and Committee on Fetus and Newborn Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use Pediatrics, April 1, 1997; 99(4): 645 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Law, E. E. L. Wang, N. MacDonald, J. McDonald, S. Dobson, F. Boucher, J. Langley, J. Robinson, I. Mitchell, and D. Stephens Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database Pediatrics, March 1, 1997; 99(3): e7 - e7. [Abstract] [Full Text] [PDF] |
||||